ATON — Stock activity · TradeandTellATON
ATON
$0.32+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$0.28 – $13.80
0% from low
Held by traders on TradeandTell
No one on the platform currently holds ATON.
Super investors & insiders
Institutions holding (13F)
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ATON yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2027 | $36M | +2875.0% | $-0.53 | $-0.53–$-0.53 | — | 1 |
| 2028 | $36M | +0.0% | $-0.53 | $-0.53–$-0.53 | — | 1 |
| 2029 | $38M | +7.7% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 2 of the last 4 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2026-01-12 | $-0.35 | $-4.13 | -1080.0% |
| 2026-01-05 | $-4.20 | $-1.26 | +70.0% |
| 2025-10-29 | $-4.20 | $-2.57 | +38.8% |
| 2024-06-06 | $-0.22 | $-1.26 | -471.8% |
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| ATONAlphaTON Capital Corp. | $0.29 | +22.68% | $666633 | — |
| BDRXBiodexa Pharmaceuticals Plc | $1.56 | +4.00% | $1M | — |
| BHVNBiohaven Ltd. | $14.85 | +3.20% | $2.2B | — |
| IMNMImmunome, Inc. | $26.42 | -5.61% | $2.5B | — |
| INBXInhibrx Biosciences Inc. | $97.01 | -1.37% |
| KTTAPasithea Therapeutics Corp. | $0.48 | -2.45% | $16M | — |
| SERSerina Therapeutics, Inc. | $2.85 | +1.06% | $43M | — |
Source: Financial Modeling Prep · peers by sector/industry